CORRECTION article

Front. Cell. Neurosci.

Sec. Cellular Neuropathology

Volume 19 - 2025 | doi: 10.3389/fncel.2025.1637837

Correction: O6-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo, and sensitivity to alisertib-carboplatin combination treatment

Provisionally accepted
Müge SakMüge Sak1Brian WilliamsBrian Williams1Andrew HeyAndrew Hey1Mayur SharmaMayur Sharma1Leslie SchierLeslie Schier1Megan WilsonMegan Wilson1Mahatma OrtegaMahatma Ortega1Alyssa LaraAlyssa Lara2Mikaela BrentlingerMikaela Brentlinger2Norman LehmanNorman Lehman1,2,3*
  • 1University of Louisville, Louisville, United States
  • 2Baylor Scott & White Health, Dallas, United States
  • 3Baylor College of Medicine, Houston, United States

This article is a correction to:

  1. A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to Temozolomide

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Falchook, G., Coleman, R.L., Roszak, A., Behbakht, K., Matulonis, U., Ray-Coquard, I., Sawrycki, P., Duska, L.R., Tew, W., Ghamande, S. and Lesoin, A., 2019. Alisertib in combination with weekly paclitaxel in patients with advanced breast cancer or recurrent ovarian cancer: a randomized clinical trial. JAMA oncology, 5(1), pp.e183773-e183773. doi:10.1001/jamaoncol.2018.3773. Falchook, G., Coleman, R.L. and Schilder, R.J., 2019. Paclitaxel and Alisertib in Recurrent Ovarian Cancer-In Reply. JAMA oncology, 5(6)

Keywords: Aurora A kinase, AURKA, O 6 -methylguanine DNA methyltransferase, MGMT, GBM, Anchorage independent growth, Clonogenicity, in vivo

Received: 29 May 2025; Accepted: 30 May 2025.

Copyright: © 2025 Sak, Williams, Hey, Sharma, Schier, Wilson, Ortega, Lara, Brentlinger and Lehman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Norman Lehman, University of Louisville, Louisville, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material